feedback

Faculty

Peter C. Taylor, MA, BM, BCh, PhD, FRCP, FRCPE
Norman Collisson Professor of Musculoskeletal Sciences
Oxford University
Director of Clinical Sciences
Botnar Research Centre
Oxford, England


Thomas Dörner, MD, PhD
Professor of Rheumatology and Clinical Immunology
Charite University Hospitals Berlin and DRFZ Berlin
Berlin, Germany


Juan J. Gómez-Reino, MD, PhD
Professor of Medicine
Fundación Ramón Dominguez
Hospital Clinico Universitario
Santiago, Spain


Accredited By

The Omnia-Prova Education Collaborative (TOPEC)

Activity Details

Free
CME

0.75 AMA PRA Category 1 Credit

Released: March 28, 2017

Expires: March 28, 2018

0.75 hours to complete

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Delineate the role of TNF and IL-6 signaling pathways in the pathophysiology of rheumatoid arthritis and the rationale for anti-cytokine therapy as a treatment approach
  2. Integrate current standards for disease activity monitoring into informing appropriate management for patients with rheumatoid arthritis
  3. Incorporate emerging clinical trial data regarding the safety and efficacy of novel IL-6 targeting agents for RA into treatment decisions
  4. Select treatments for patients that improve patient outcomes based on an understanding of the differences between TNF cycling and switching

Target Audience

Physicians, nurse practitioners, and physician assistants who specialize in rheumatology and internal medicine.

Requirements for Successful Completion

75%

Media

Internet

Conflict of Interest Policy/Disclosure Statement

In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Peter C. Taylor, MA, BM, BCh, PhD, FRCP, FRCPE, discloses the following relationships with commercial interests: AbbVie, Biogen, BMS, GSK, Janssen, Lilly, Novartis, Pfizer, Sandoz, Sanofi, and UCB (Consulting Fees); Abide Therapeutics, Celgene, Galapagos, GSK, and UCB (Contracted Research).
  • Thomas Dörner, MD, PhD, discloses the following relationships with commercial interests: Ablynx, Chugai, Eli Lilly, and Roche (Consulting Fees); Charite CRO, Janssen, and Sanofi (Contracted Research).
  • Juan J. Gómez-Reino, MD, PhD, discloses the following relationships with commercial interests: BMS, Pfizer (Consulting Fees); Roche (Contracted Research).

RMEI Medical Education, LLC

  • Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
  • Beth Paczolt Weiner, MD, has no affiliations with commercial interests to disclose.
  • Nora Hartley has no affiliations with commercial interests to disclose.

The Omnia-Prova Education Collaborative (TOPEC)

  • Sean T. Barrett has no affiliations with commercial interests to disclose.
  • Barry A. Fiedel, PhD, has no affiliations with commercial interests to disclose.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Omnia-Prova Education Collaborative (TOPEC) and RMEI Medical Education, LLC. TOPEC is accredited by the ACCME to provide continuing medical education for physicians.

Designation of Credit

The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 0.75 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.

Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

Statement of Commercial Support

This activity is supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

Contact Information for Questions about the Activity

For any technical issues or issues with your CME Certificate, please visit: http://www.realcme.com/cms/support-center

Supported Browsers

Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.